跳至主要内容
临床试验/JPRN-UMIN000005712
JPRN-UMIN000005712已完成2 期

Prevention of the chemotherapy-induced oral mucositis by the rebamipide in breast cancer patients (Phase II) - Prevention of the chemotherapy-induced oral mucositis by the rebamipide in breast cancer patients -Cinderella Study BC2011

Cinderella Study Group0 个研究点目标入组 160 人开始时间: 2011年8月1日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
160

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 70years-old(—)
性别
Female

入选标准

  • 未提供

排除标准

  • 1)Patient with impossible oral ingestion of medicine 2)Patients with allergy history for rebamipide 3)Patient with breast cancer relapse or metastasis 4)Women during pregnancy, and women who has likelihood of pregnancy or the intention or breast-feeding 5)Patient who judged that doctor is improper excluding the above-mentioned

研究者

发起方
Cinderella Study Group

相似试验